Ana Barac, MD, PhD, and Laleh Amiri-Kordestani, MD, offer a unique perspective on the development and safety of novel therapeutics, with a focus on cardio-oncology.

JACC: CardioOncology Pulse - Top Takeaways on 'Perspective from the FDA: How to Keep Pace with New Drug Development and Drug Safety' at ACC Advancing the Cardiovascular Care of the Cancer Patient

In this podcast series, editors-in-chief from the JACC family of specialty journals provide highlights and summarize key findings for select issues. Published by the American College of Cardiology, the JACC Journals publish peer-reviewed articles on all aspects of cardiovascular disease, including original clinical studies, translational investigations with clear clinical relevance, state-of-the art papers, and review articles. They are top ranked for impact factor and their manuscripts are among the most covered by media outlets, most talked about on social media, and most read online.

Medicine

Science & Medicine

Science

Health & Fitness

Life Sciences

Commentary by Dr. Sadeer Al-Kindi and Dr. Carrie R. Howell

JACC: Advances - Cardiometabolic Disease Staging and Major Adverse Cardiovascular Event Prediction in 2 Prospective Cohorts

Commentary by Dr. Candice Silversides, Dr. Emily Lau, and Dr. Nandita Scott

JACC: Advances - Recommendations for the Management of High-Risk Cardiac Delivery: ACC Cardiovascular Disease in Women Committee Panel

Commentary by Dr. Candice Silversides and Dr. Kamala Tamirisa

JACC: Advances - Radiation Exposure, Training, and Safety in Cardiology

Commentary by Dr. Candice Silversides and Dr. Ashok Krishnaswami

JACC: CardioOncology Pulse - Top Takeaways on 'Perspective from the FDA: How to Keep Pace with New Drug Development and Drug Safety' at ACC Advancing the Cardiovascular Care of the Cancer Patient

Download our free app to listen on your phone